Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 114 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1131 10.4 months Advanced NSCLC 4 Chemotherapy
Hygeia Hospital Greece 9/2002
Treatment Details: Patients: This Phase III study involved 509 patients with advanced (stages IIIA, IIIB, and IV) non-small-cell lung cancer. None of the patients had been administered prior chemotherapy. Pa
 
1132 10.4 months Advanced NSCLC 4 Chemotherapy
University of Virginia Health Services United States 3/2005
Treatment Details: Patients: This Phase II study involved 39 patients diagnosed with advanced non-small cell lung cancer. Twenty-nine patients were men, and ten were women. The median age was 62. Metastatic
 
1133 10.4 months Recurrent malignant gliomas 5 Chemotherapy
Massachusetts General Hospital United States 1/2004
Treatment Details: Patients: This Phase II study involved 18 patients with recurrent malignant gliomas. Of the 18 patients, 12 patients had recurrent glioblastoma multiforme, 5 patients had recurrent anaplast
 
1134 10.4 months Advanced NSCLC 5 Chemotherapy
Hygeia Hospital Greece 1/2008
Treatment Details: Patients: This phase III study involved 452 patients with advanced, inoperable, non-small-cell lung cancer. The median age was 63, ranging from 36 to 83 years of age. The majority of patie
 
1135 10.4 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
The Arthur G James Cancer Hospital and Richard J Solove Research Institute United States 11/2008
Treatment Details: Patients: This phase 2 study involved patients with advanced non-small-cell lung cancer. They ranged in age from 36 to 78 years of age. There were two groups of patients; one group had 39
 
1136 10.4 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
Doce de Octobre University Hospital Spain 3/2006
Treatment Details: Patients: This Phase III study involved 670 patients with advanced non-small-cell lung cancer. None of the patients had received treatment before the study. The patients were randomly divi
 
1137 10.4 months Metastatic breast cancer 5 Chemotherapy
Vall d'Hebron University Hospital Spain 9/2010
Treatment Details: Patients: This phase II study involved 269 women with locally advanced or metastatic breast cancer who had received prior chemotherapy with anthracycline, taxane, and capecitabine. The med
 
1138 10.4 months Metastatic colorectal cancer 5 Biologic therapy
The Queen Elizabeth Hospital and University of Adelaide Australia 4/2014
Treatment Details: Patients: This phase 3 study involved previously treated metastatic colorectal cancer patients with wild-type KRAS exon 2 cancer who were divided into two separate treatment groups. Group
 
1139 10.4 months Urothelial cancer 5 Chemotherapy
Alexianer Hospital Maria Hilf GmbH Germany 3/2014
Treatment Details: Patients: This phase 2 study involved advanced or metastatic urothelial cancer patients who were separated into two different treatment groups. Group A consisted of 49 patients with a medi
 
1140 10.4 months Advanced non-squamous NSCLC 5 Chemotherapy
Poznan University of Medical Sciences Poland 10/2012
Treatment Details: Patients: This phase 3 study involved platinum-pretreated patients with advanced or metastatic non-squamous non-small-cell lung cancer patients who were divided into two separate treatment
 
Page 114 of 187  | Previous Page  | Next Page